Pzena Investment Management Adds $8M in Globe Life Inc. ($GL)

Pzena Investment Management boosted its holdings in Globe Life Inc. by over 5%, reflecting confidence in the insurance firm's prospects.

Key Points

  • Pzena Investment Management added 50,199 shares of Globe Life Inc., increasing its holdings by 5.14% to 1,026,246 shares valued at $171.78 million.
  • Globe Life Inc. trades near $167.39 with a market cap of $12.99 billion and a P/E ratio of 11.54, providing life and health insurance products.
  • Analysts maintain a 'buy' rating with price targets up to $208, while insiders, including CEO Frank Svoboda, have been active in trading shares.

Pzena Investment Management has boosted its stake in Globe Life Inc. (NYSE:GL), adding 50,199 shares, according to its latest filing with the SEC as of April 24, 2026. This increase brings Pzena's total holdings to 1,026,246 shares, representing a 5.14% rise. The total value of these shares is approximately $171.78 million.

What Changed in Pzena Investment Management's Globe Life Inc. Position

Pzena Investment Management increased its holdings in Globe Life Inc. from 976,047 shares to 1,026,246 shares, marking an additional 50,199 shares. This change reflects a 5.14% boost in their position, with the total value of the shares now reaching about $171.78 million.

Other Institutional Activity in Globe Life Inc.

Among other institutional investors, BlackRock, Inc. trimmed its position by 146,546 shares, holding 5,542,531 shares valued at $771.35 million. Vanguard Capital Management LLC established a position with 5,149,992 shares worth around $716.72 million. Invesco Ltd. added 67,674 shares, bringing its total to 4,016,350 shares valued at approximately $558.96 million. Meanwhile, State Street Corp increased its stake by 485,155 shares, ending with 3,658,664 shares valued at $509.18 million.

Globe Life Inc. Stock Snapshot

Shares of Globe Life Inc. are trading near $167.39 on the NYSE. The company has a market capitalization of approximately $12.99 billion and a P/E ratio of 11.54. Its 52-week range spans from $116.73 to $169.58, with a 50-day moving average of $153.47 and a 200-day moving average of $142.55. The company has a beta of 0.499, indicating lower volatility compared to the market.

Recent Earnings

Globe Life Inc. reported revenue of $6.07 billion, with a growth rate of 5.4%. The company achieved a net margin of 19.38% and a return on equity of 20.46%. The next earnings announcement is expected on July 22, 2026.

Dividend

Globe Life Inc. pays an annual dividend rate of $1.32, yielding 0.79% with a payout ratio of 7.89%. The company's consistent dividend payments reflect its stable financial performance.

Insider Buying and Selling at Globe Life Inc.

CEO Frank Svoboda was active in recent trading, selling 10,000 shares on June 12, 2026, at an average price of $166.68, and buying 10,000 shares at $100.74 on the same day. He repeated these transactions on June 11, 2026, selling at $164.89 and buying at $100.74.

Analysts Set New Price Targets

On May 26, 2026, Piper Sandler maintained a 'buy' rating with a $175 price target for Globe Life Inc. Morgan Stanley also maintained a 'buy' rating with a target of $181 on May 21, 2026. Truist Securities upheld its 'buy' rating with a $185 target on April 24, 2026. The consensus recommendation is 'buy', with a mean target price of $175.91 from 11 analysts.

About Globe Life Inc.

Globe Life Inc., headquartered in McKinney, Texas, provides life and supplemental health insurance products to lower middle- and middle-income families in the U.S. The company operates through segments including Life Insurance, Supplemental Health Insurance, and Investments. It markets its products via direct-to-consumer channels and independent agents. Globe Life, formerly known as Torchmark Corporation, was founded in 1900 and is led by CEO Frank Martin Svoboda.

Bottom Line

Pzena Investment Management's increased stake in Globe Life Inc. highlights its confidence in the company's potential. Investors often track such moves for insights, though it's important to remember that 13F filings are retrospective and may not reflect current positions. Globe Life's steady financial performance and analyst support suggest a positive outlook, but as always, investors should conduct their own research.

See Also

This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.